Presage Biosciences develops the patented CIVO (Comparative In Vivo Oncology) platform, which delivers microdoses of multiple investigational drugs or combinations into different regions of a patient's tumor
Presage Biosciences develops the patented CIVO (Comparative In Vivo Oncology) platform, which delivers microdoses of multiple investigational drugs or combinations into different regions of a patient's tumor. It analyzes spatial molecular and cellular responses in the tumor microenvironment to support translational oncology research and cancer drug development.